toxicology exam and a standardized psychological autopsy [3] . MDD subjects with co-morbid psychiatric disorders were excluded. Antidepressant drug exposure was assessed by clinical data from structured interviews, review of records and toxicology studies. All cases and controls were white Caucasian and were selected for rapid modes of death and short agonal phases, to limit the influence of agonal factors on RNA quality and pH [4] . All selected brains were analyzed for adequate brain pH (>6.4) and RNA integrity by optical density (OD≥ 1.6) and Agilent bioanalyzer analysis (Agilent Technologies, Palo Alto, CA; RIN expert scoring system ≥ 7) as previously described [5] . All procedures were approved by the Institutional Review Board and Committee for Correlation and p-values were computed using the percentile bootstrap (see statistical methods). Genes with p-values that survive a false discovery rate (FDR) cutoff of less than or equal to 30% are noted in 5% increments. Only genes with correlations greater than 0.7 or less than -0.7 in one condition were selected for differential analysis.
A sample of the 
